Skip to content
HowShorted

How shorted is COSCIENS Biopharma Inc.? CSCIF

0.07%
of shares outstanding reported short ยท settlement date 31 Jan 2025
vs previous report
โˆ’0.10
5 reports (~10 weeks)
โˆ’0.38
days to cover
1.00
Aggregate net short position time series for COSCIENS Biopharma Inc.

Markers along the chart's base: โ–ฒ results announced (an 8-K reporting results was filed) โ–ฒ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for COSCIENS Biopharma Inc. days to cover

Fails to deliver

The SEC's fails-to-deliver figure for CSCIF: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Last balance on file
40
20 Aug 2026
Highest in window
19,533
22 Jun 2026
Days with a balance
26
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for COSCIENS Biopharma Inc. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 20K shares.

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Share on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Consumer goods

History

Full reported short interest history
Settlement dateShort %Change
31 Jan 20250.07%โˆ’0.10
15 Jan 20250.17%โˆ’0.01
31 Dec 20240.18%โˆ’0.16
30 Apr 20240.34%โˆ’0.01
15 Apr 20240.35%โˆ’0.10
28 Mar 20240.45%โˆ’0.15
15 Mar 20240.60%+0.19
29 Feb 20240.41%โˆ’0.07
15 Feb 20240.48%+0.05
31 Jan 20240.43%โˆ’0.08
12 Jan 20240.51%โˆ’0.70
15 Sep 20231.21%โˆ’0.09
31 Aug 20231.30%โˆ’0.01
15 Aug 20231.31%+0.02
31 Jul 20231.29%โˆ’0.08
14 Jul 20231.37%+0.09
30 Jun 20231.28%โˆ’0.20
15 Jun 20231.48%โˆ’0.20
31 May 20231.68%0.00
15 May 20231.68%โˆ’0.28
28 Apr 20231.96%+0.37
14 Apr 20231.59%+0.05
31 Mar 20231.54%+0.03
15 Mar 20231.51%โˆ’0.28
28 Feb 20231.79%+0.12
15 Feb 20231.67%โˆ’0.11
31 Jan 20231.78%โˆ’0.04
13 Jan 20231.82%0.00
15 Jul 20221.82%+0.21
30 Jun 20221.61%โˆ’0.11
15 Jun 20221.72%0.00
31 May 20221.72%โˆ’0.28
13 May 20222.00%โˆ’0.14
29 Apr 20222.14%โˆ’0.16
14 Apr 20222.30%โˆ’0.03
31 Mar 20222.33%โˆ’0.01
15 Mar 20222.34%+0.02
28 Feb 20222.32%โˆ’0.03
15 Feb 20222.35%โˆ’0.28
31 Jan 20222.63%โˆ’0.45
14 Jan 20223.08%0.00
31 Dec 20213.08%โˆ’3.37
15 Sep 20216.45%โˆ’0.43
31 Aug 20216.88%โˆ’0.31
13 Aug 20217.19%โˆ’0.91
30 Jul 20218.10%+0.80
15 Jul 20217.30%+0.15
30 Jun 20217.15%โˆ’1.33
15 Jun 20218.48%+0.99
28 May 20217.49%โˆ’0.23
14 May 20217.72%โˆ’0.85
30 Apr 20218.57%โˆ’1.21
15 Apr 20219.78%โˆ’2.55
31 Mar 202112.33%+5.83
15 Mar 20216.50%+0.69
26 Feb 20215.81%+0.26
12 Feb 20215.55%โˆ’2.57
29 Jan 20218.12%โˆ’0.25
15 Jan 20218.37%+4.64
31 Dec 20203.73%+3.45
15 Jun 20200.28%โˆ’0.22
29 May 20200.50%+0.13
15 May 20200.37%โˆ’0.06
30 Apr 20200.43%โˆ’0.05
15 Apr 20200.48%โˆ’0.47
31 Mar 20200.95%โˆ’0.19
13 Mar 20201.14%+0.31
28 Feb 20200.83%โˆ’0.13
14 Feb 20200.96%โˆ’0.80
15 Jan 20201.76%โˆ’0.10
31 Dec 20191.86%โˆ’2.45
13 Sep 20194.31%+2.08
30 Aug 20192.23%โˆ’0.24
15 Aug 20192.47%+0.03
31 Jul 20192.44%โˆ’0.17
15 Jul 20192.61%โˆ’0.13
28 Jun 20192.74%+0.06
14 Jun 20192.68%โˆ’1.07
31 May 20193.75%โˆ’0.35
15 May 20194.10%โˆ’1.31
30 Apr 20195.41%โˆ’0.73
15 Apr 20196.14%+0.32
29 Mar 20195.82%โˆ’0.01
15 Mar 20195.83%โˆ’1.71
28 Feb 20197.54%โˆ’0.94
15 Feb 20198.48%+0.45
31 Jan 20198.03%+1.71
15 Jan 20196.32%+2.42
31 Dec 20183.90%+1.46
14 Sep 20182.44%โˆ’0.09
31 Aug 20182.53%โˆ’0.26
15 Aug 20182.79%โˆ’0.35
31 Jul 20183.14%โˆ’0.33
13 Jul 20183.47%โˆ’0.15
29 Jun 20183.62%โˆ’0.08
15 Jun 20183.70%โˆ’0.07
31 May 20183.77%+0.49
15 May 20183.28%+0.21
30 Apr 20183.07%โˆ’0.14
13 Apr 20183.21%โˆ’0.23
29 Mar 20183.44%โˆ’0.20
15 Mar 20183.64%โˆ’0.29
28 Feb 20183.93%โˆ’0.12
15 Feb 20184.05%โˆ’0.19
31 Jan 20184.24%โˆ’0.61
12 Jan 20184.85%โ€“

Newest first. Scroll inside the table for earlier dates, back to 12 Jan 2018.

Frequently asked questions

How shorted is COSCIENS Biopharma Inc. right now?
0.07% of COSCIENS Biopharma Inc.'s (CSCIF) shares outstanding were reported short for settlement date 31 Jan 2025, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this CSCIF's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is CSCIF's days to cover?
1.00 days for settlement date 31 Jan 2025: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.